Search results for "Neumonia"

showing 10 items of 657 documents

Varicella-zoster Virus Pneumonia In An Adult Population. Has The Pattern Of Mortality Been Changed?

2010

PneumoniaPediatricsmedicine.medical_specialtybusiness.industryAdult populationVaricella zoster virusMedicinebusinessmedicine.diseasemedicine.disease_causeD25. COMMUNITY ACQUIRED PNEUMONIA: CONTROVERSIES IN MANAGEMENT
researchProduct

WHY LOW RISK COMMUNITTY ACQUIRED PNEUMONIA (PSI I-III) ARE ADMITTED TO ICU?

2010

Pneumoniamedicine.medical_specialtybusiness.industryEmergency medicineMedicineMedical emergencybusinessmedicine.diseaseB50. RESPIRATORY TRACT INFECTIONS: DIAGNOSIS AND PROGNOSIS
researchProduct

Less Is More: Different Weight of the ATS/IDSA'07 Minor Criteria on Mortality Prediction in Severe Pneumonia (SCAP).

2009

Pneumoniamedicine.medical_specialtybusiness.industryInternal medicinemedicineMortality predictionmedicine.diseasebusinessA47. COMMUNITY ACQUIRED PNEUMONIA AND HEALTHCARE ASSOCIATED PNEUMONIA
researchProduct

CHARACTERISTICS OF COMMUNITTY ACQUIRED PNEUMONIA IN VERY ELDERLY PATIENTS

2010

Pneumoniamedicine.medical_specialtybusiness.industryInternal medicinemedicinemedicine.diseasebusinessD25. COMMUNITY ACQUIRED PNEUMONIA: CONTROVERSIES IN MANAGEMENT
researchProduct

Mitochondrial dysfunction and host immune response during pneumococcal pneumonia : impact of mechanical ventilation?

2020

Lung damage induced by mechanical ventilation (MV) worsens the prognosis of pneumonia. Mitochondrial dysfunctions could account for such deleterious effects. Accordingly, data obtained from both in vitro and in vivo experimental studies, as well as in ventilated patients with acute respiratory distress syndrome, show that mitochondrial alarmins, especially mitochondrial DNA, are released in the alveolar compartment as a result of the cyclic stretch, and could thus represent one link between the mechanical insult and the sterile inflammation leading to VILI (ventilator-induced lung injury). In rabbits, we show herein that adverse and prolonged MV worsens the prognosis of pneumococcal pneumon…

Pneumopathie[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyStreptococcus pneumoniaeMechanical ventilationBiogénèse mitochondrialeMitochondrial biogenesisVentilation mécaniqueMitophagyDysfonction mitochondrialePneumoniaMitochondrial dysfunctionMitophagie[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Facial masks in children: the position statement of the Italian pediatric society

2020

AbstractFacial masks may be one of the most cost-effective strategies to prevent the diffusion of COVID 19 infection. Nevertheless, fake news are spreading, alerting parents on dangerous side effects in children, such as hypercapnia, hypoxia, gut dysbiosis and immune system weakness. Aim of the Italian Pediatric Society statement is to face misconception towards the use of face masks and to spread scientific trustable information.

Position statementWeakness2019-20 coronavirus outbreakmedicine.medical_specialtyConsensusCoronavirus disease 2019 (COVID-19)Pneumonia ViralFake newBetacoronavirus03 medical and health sciences0302 clinical medicineFacial mask030225 pediatricsDisease Transmission InfectiousmedicineHumansInfection control030212 general & internal medicinePsychiatryChildPandemicsChildrenCOVIDInfection ControlMaskPandemicBetacoronaviruSARS-CoV-2business.industryCoronavirus InfectionMaskslcsh:RJ1-570COVID-19lcsh:PediatricsEquipment DesignSettore MED/38Face masksDisease Transmission InfectiouFake newsCommentaryGut dysbiosisFake newsmedicine.symptomCoronavirus InfectionsbusinessHumanItalian Journal of Pediatrics
researchProduct

Manejo perioperatorio de pacientes con sospecha o infección grave por coronavirus SARS-CoV-2 programados para implante de dispositivos electrónicos p…

2020

Resumen La infeccion por SARS-CoV-2 ha evolucionado hasta convertirse progresivamente en una pandemia declarada por la Organizacion Mundial de la Salud (OMS) que ha obligado a las organizaciones de salud a nivel mundial, regional y local a adoptar una serie de medidas para hacer frente al COVID-19 e intentar disminuir su impacto, no solo en el ambito social sino tambien en el ambito sanitario, modificandose las pautas de actuacion en los servicios de salud. Dentro de estas recomendaciones que incluyen las Unidades de Tratamiento del Dolor, los pacientes con sospecha o infeccion confirmada por SARS-CoV-2 pueden encontrase en situacion de espera para intervencion no demorable para implante o …

Postoperative CareSARS-CoV-2business.industryPneumonia ViralCOVID-19Cancer PainCritical Care and Intensive Care MedicinePerioperative CareArtículo EspecialBetacoronavirusWearable Electronic Devices03 medical and health sciences0302 clinical medicineAnesthesiology and Pain MedicineHumansMedicine030212 general & internal medicineChronic PainCoronavirus InfectionsbusinessPandemicsHumanities030217 neurology & neurosurgeryRevista Española de Anestesiología y Reanimación
researchProduct

Pneumococcal conjugate vaccines: proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemothera…

2003

Globally, Streptococcus pneumoniae is a leading cause of invasive and noninvasive disease in infants and young children. The emergence of antibiotic-resistant strains has increased interest in prevention through immunization. Currently, the only available conjugate pneumococcal vaccine is a seven-valent formulation, PNCRM7. This paper presents excerpts from a symposium that provided an update of ongoing surveillance data and clinical trials evaluating pneumococcal conjugate vaccines. The topics addressed included: (1) PNCRM7 postmarketing safety data; (2) the impact of PNCRM7 in premature infants; (3) the direct and indirect effect of pneumococcal conjugate vaccines on colonization; (4) the…

Potential impactChemotherapymedicine.medical_specialtyGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industrymedicine.medical_treatmentPublic Health Environmental and Occupational HealthAntimicrobialmedicine.disease_causeClinical trialInfectious DiseasesPneumococcal vaccineImmunizationStreptococcus pneumoniaeImmunologyMolecular MedicineMedicinebusinessIntensive care medicineConjugateVaccine
researchProduct

Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights

2020

The current coronavirus disease 2019 (COVID-19) pandemic has led the scientific community to breach new frontiers in the understanding of human physiology and disease pathogenesis. It has been hypothesized that the human dipeptidyl peptidase 4 (DPP4) enzyme receptor may be a functional target for the spike proteins of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Since DPP4-inhibitors are currently used for the treatment of patients with type-2 diabetes (T2DM), there is currently high interest in the possibility that these agents, or incretin-based therapies (IBTs) in general, may be of benefit against the new coronavirus infection. Diabetes is associated with increased COV…

Prognostic variableCoronavirus disease 2019 (COVID-19)Pneumonia ViralIncretin030209 endocrinology & metabolism030204 cardiovascular system & hematologymedicine.disease_causeBioinformaticsIncretinsSeverity of Illness IndexGlucagon-Like Peptide-1 ReceptorBetacoronavirus03 medical and health sciences0302 clinical medicineDiabetes mellitusPandemicSeverity of illnessHumansHypoglycemic AgentsMedicinePharmacology (medical)PandemicsDipeptidyl peptidase-4CoronavirusPharmacologyDipeptidyl-Peptidase IV InhibitorsSARS-CoV-2business.industryCOVID-19medicine.diseaseDiabetes Mellitus Type 2Inflammation MediatorsCoronavirus InfectionsCardiology and Cardiovascular Medicinebusinessdiabetes DPP4 GLP1 incretins Betacoronavirus COVID-19 Coronavirus Infections Diabetes Mellitus Type 2 Dipeptidyl-Peptidase IV Inhibitors Glucagon-Like Peptide-1 Receptor Humans Hypoglycemic Agents Incretins Inflammation Mediators Pandemics Pneumonia Viral SARS-CoV-2 Severity of Illness Index
researchProduct

Targeting SARS-CoV-2 RBD Interface: a Supervised Computational Data-Driven Approach to Identify Potential Modulators

2020

Coronavirus disease 2019 (COVID-19) has spread out as a pandemic threat affecting over 2 million people. The infectious process initiates via binding of SARS-CoV-2 Spike (S) glycoprotein to host angiotensin-converting enzyme 2 (ACE2). The interaction is mediated by the receptor-binding domain (RBD) of S glycoprotein, promoting host receptor recognition and binding to ACE2 peptidase domain (PD), thus representing a promising target for therapeutic intervention. Herein, we present a computational study aimed at identifying small molecules potentially able to target RBD. Although targeting PPI remains a challenge in drug discovery, our investigation highlights that interaction between SARS-CoV…

Protein domainPneumonia ViralDruggabilityDrug Evaluation Preclinicalprotein-protein interactionsComputational biologyBiologyMolecular Dynamics SimulationPeptidyl-Dipeptidase AMolecular dynamics01 natural sciencesBiochemistryMolecular Docking SimulationAntiviral Agentsdockingmolecular dynamicProtein–protein interactionSmall Molecule LibrariesBetacoronavirusProtein DomainsDrug DiscoveryHumansGeneral Pharmacology Toxicology and PharmaceuticsPandemicsPharmacologyFull Paperpharmacophore010405 organic chemistryDrug discoverySARS-CoV-2Organic ChemistryCOVID-19Small molecule0104 chemical sciencesProtein-Protein InteractionMolecular Docking Simulation010404 medicinal & biomolecular chemistryDocking (molecular)Spike Glycoprotein CoronavirusdockingMolecular MedicineAngiotensin-Converting Enzyme 2PharmacophoreCoronavirus InfectionsProtein Binding
researchProduct